As the loss of ERα expression is the main reason leading to ERα− breast cancer cells resistant to TAM [6, 7], we then asked whether VORAS and Z-LIG could restore the ERα expression in ERα− breast cancer cells. The gene discussed is ESR1; the disease is breast carcinoma.